Quick Answer
SeaStar Medical Holding Corp reported Stockholders Equity of $10.42 million for the year ending 2025.
- SeaStar Medical Holding Corp showed an increase of +577.1% in Stockholders Equity from 2024 to 2025.
- This data is from SeaStar Medical Holding Corp's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: -$8.93 million | Q2 2021: -$10.92 million | Q3 2021: -$10.68 million | Q1 2022: -$3.82 million | Q2 2022: -$4.37 million | Q3 2022: -$5.91 million | Q1 2023: -$23.38 million | Q2 2023: -$11.76 million | Q3 2023: -$16.02 million | Q1 2024: -$4.48 million | Q2 2024: -$6.90 million | Q3 2024: -$2.1 thousand | Q1 2025: $565.0 thousand | Q2 2025: $3.34 million | Q3 2025: $11.46 million.
- Over the full 9 years of available data (2020 to 2025), SeaStar Medical Holding Corp's Stockholders Equity has grown by 489.8%.
- Historical annual values: Fiscal year 2025: $10.42 million | Fiscal year 2024: -$2.18 million | Fiscal year 2023: -$13.87 million | Fiscal year 2023: -$16.02 million | Fiscal year 2023: -$11.76 million | Fiscal year 2023: -$23.38 million | Fiscal year 2022: -$20.76 million | Fiscal year 2021: -$2.82 million | Fiscal year 2020: $1.77 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: